Cytokeratin–20 Reverse–Transcriptase Polymerase Chain Reaction as a New Tool for the Detection of Circulating Tumor Cells in Peripheral Blood and Bone Marrow of Bladder Cancer Patients

No abstract is available for this paper.

• Publication year

  2001

• Venue

  European Urology

• Publication date

  2001-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1159/000052496PMID 11464030
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Limitations of detection of bone-marrow micrometastasis in prostate carcinoma patients by CK18/PSA immunocytochemistry and PSA RT-PCR.

  2000cited by this paper
• Significant detection of circulating cancer cells in the blood by reverse transcriptase-polymerase chain reaction during colorectal cancer resection.

  2000cited by this paper
• Detection and clinical importance of micrometastatic disease.

  1999cited by this paper
• Detection of cytokeratins 19/20 and guanylyl cyclase C in peripheral blood of colorectal cancer patients

  1999cited by this paper
• Detection of micrometastasis by cytokeratin 20 RT-PCR is limited due to stable background transcription in granulocytes

  1999cited by this paper
• Detection of colorectal cancer cells in peripheral blood by reverse‐transcriptase polymerase chain reaction for cytokeratin 20

  1998cited by this paper
• Cytokeratin 20 mRNA in peripheral venous blood of colorectal carcinoma patients.

  1998cited by this paper
• Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients.

  1998cited by this paper
• The value of a reverse transcriptase polymerase chain reaction assay in preoperative staging and followup of patients with prostate cancer.

  1998cited by this paper
• Keratin 19 mRNA is detectable by RT-PCR in lymph nodes of patients without breast cancer.

  1997cited by this paper
• Detection of disseminated tumor cells in peripheral blood of colorectal cancer patients

  1997cited by this paper
• Reverse transcriptase-polymerase chain reaction (RT-PCR)-controlled immunomagnetic purging of breast cancer cells using the magnetic cell separation (MACS) system: a sensitive method for monitoring purging efficiency.

  1997cited by this paper
• Reverse transcriptase-polymerase chain reaction analysis of cytokeratin 19 expression in the peripheral blood mononuclear cells of normal female blood donors.

  1997cited by this paper
• Comparative analysis of bone marrow and venous blood isolates from gastrointestinal cancer patients for the detection of disseminated tumor cells using reverse transcription PCR.

  1997cited by this paper
• Early tumor cell dissemination in patients with clinically localized carcinoma of the prostate.

  1997cited by this paper
• Circulating micrometastases following oncological surgery.

  1996cited by this paper
• The detection of disseminated tumor cells in bone marrow from colorectal‐cancer patients by a cytokeratin‐20‐specific nested reverse‐transcriptase‐polymerase‐chain reaction is related to the stage of disease

  1996cited by this paper
• Frequency and prognostic significance of isolated tumour cells in bone marrow of patients with non-small-cell lung cancer without overt metastases.

  1996cited by this paper
• Prognostic significance of bone marrow micrometastases in patients with gastric cancer.

  1996cited by this paper
• Tumor cells in blood shed from the surgical field.

  1995cited by this paper
• The molecular detection of circulating tumour cells.

  1995cited by this paper
• Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction.

  1995cited by this paper
• Tumour cell detection in the bone marrow of breast cancer patients at primary therapy: results of a 3-year median follow-up.

  1994cited by this paper
• Immunocytological detection of micrometastatic cells: Comparative evaluation of findings in the peritoneal cavity and the bone marrow of gastric, colorectal and pancreatic cancer patients

  1994cited by this paper
• The human gene encoding cytokeratin 20 and its expression during fetal development and in gastrointestinal carcinomas.

  1993cited by this paper
• The value of pathologic factors in predicting cancer‐specific survival among patients treated with radical cystectomy for transitional cell carcinoma of the bladder and prostate

  1993cited by this paper
• PCR amplification of long DNA fragments.

  1992cited by this paper
• Cytokeratin 20 in human carcinomas. A new histodiagnostic marker detected by monoclonal antibodies.

  1992cited by this paper
• Are micrometastases clinically relevant?

  1992cited by this paper
• Prognostic significance of micrometastatic tumour cells in bone marrow of colorectal cancer patients.

  1992cited by this paper
• Micrometastatic tumour cells in bone marrow of patients with gastric cancer: methodological aspects of detection and prognostic significance.

  1991cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Human urologic cancer cell lines.

  1980cited by this paper
• Human urologic cancer cell lines.

  1980cited by this paper
• Characterization of WiDr: A human colon carcinoma cell line

  1979cited by this paper
• Isolation of mononuclear cells and granulocytes from human blood.

  1968cited by this paper

• The Use of Circulating Tumor Cells in T1 Stage Non-muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis

  2024cites this paper
• Liquid biopsies for detection, surveillance, and prognosis of urothelial cancer: a future standard?

  2023cites this paper
• Disseminierte Tumorzellen beim Harnblasenkarzinom

  2022cites this paper
• Tumor heterogeneity in muscle-invasive bladder cancer

  2020cites this paper
• Diagnostic and prognostic roles of CK20 in the pathology of urothelial lesions. A systematic review.

  2019cites this paper
• Detektion und Topographie disseminierter Tumorzellen in Lymphknoten bei Prostatakrebspatienten mittels quantitativer Polymerasekettenreaktion und Nachweis des Markers Kallikrein 4

  2018cites this paper
• Circulating tumor cells in bladder cancer: Emerging technologies and clinical implications foreseeing precision oncology.

  2018cites this paper
• The current status and clinical value of circulating tumor cells and circulating cell-free tumor DNA in bladder cancer

  2017cites this paper
• Circulating tumour cells as biomarkers of prostate, bladder, and kidney cancer

  2017cites this paper
• Detection of Circulating Tumour Cells in Urothelial Cancers and Clinical Correlations: Comparison of Two Methods

  2017cites this paper
• The prognostic and diagnostic value of circulating tumor cells in bladder cancer and upper tract urothelial carcinoma: a meta-analysis of 30 published studies

  2017cites this paper
• Clinical Significance of Early Changes in Circulating Tumor Cells from Patients Receiving First-Line Cisplatin-Based Chemotherapy for Metastatic Urothelial Carcinoma1

  2016cites this paper
• Hydroxyethyl starch 200/0.5 decreases circulating tumor cells of colorectal cancer patients and reduces metastatic potential of colon cancer cell line through inhibiting platelets activation

  2015cites this paper
• Do Circulating Tumor Cells Have a Role in Deciding on Adjuvant Chemotherapy After Radical Cystectomy?

  2015cites this paper
• Prostata- und Harnblasenkarzinom

  2014cites this paper
• [Prostate and bladder cancer: detection of disseminated tumor cells in bone marrow].

  2014cites this paper
• [Mechanisms of tumour cell dissemination and methods for detection of circulating tumour cells in transitional cell carcinoma].

  2011cites this paper
• Low molecular weight heparins for thromboprophylaxis during induction chemotherapy in patients with multiple myeloma.

  2011cites this paper
• Mechanismen der Tumorzelldissemination und Nachweis zirkulierender Tumorzellen beim Urothelkarzinom

  2011cites this paper
• Diagnostic value of circulating tumor cell detection in bladder and urothelial cancer: systematic review and meta-analysis

  2011influential citation
• Long-term follow-up of bladder cancer patients with disseminated tumour cells in bone marrow.

  2011cites this paper
• Anforderungen an eine klinische Datenbank beim Harnblasenkarzinom: Datenbanktheorie und Auswahl der Parameter

  2011cites this paper
• Serum and tissue profiling in bladder cancer combining protein and tissue arrays.

  2010cites this paper
• Urine cytology and adjunct markers for detection and surveillance of bladder cancer.

  2010cites this paper
• Molekulare Marker in Diagnostik und Therapie des Urothelkarzinoms

  2010cites this paper
• [Molecular markers in the diagnostics and therapy of urothelial cancer].

  2010cites this paper
• Platinum Priority – Bladder Cancer Long-term Follow-up of Bladder Cancer Patients with Disseminated Tumour Cells in Bone Marrow

  2010cites this paper
• Anemia y trombopenia aisladas por infiltración de médula ósea de un carcinoma urotelial de vejiga

  2009cites this paper
• Detection of circulating tumor cells in bladder cancer patients.

  2009cites this paper
• ESTUDIO MOLECULAR Y CITOGENÉTICO DEL CARCINOMA UROTELIAL: DETECCIÓN TEMPRANA DE LA ENFERMEDAD Y DE SU DISEMINACIÓN

  2008cites this paper
• Muskelinvasives Urothelkarzinom der Harnblase

  2008cites this paper
• [Muscle-invasive urothelial carcinoma of the bladder. Detection and topography of micrometastases in lymph nodes].

  2008cites this paper
• Lymph node metastasis in bladder cancer.

  2006cites this paper
• Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.

  2006cites this paper
• Nodal staging and lymphadenectomy in patients undergoing radical cystectomy

  2006cites this paper
• Nachweis von disseminierten Tumorzellen anhand einer Genexpression von CK-20 und MUC7 im Knochenmark bei Patienten mit lokal fortgeschrittenem Urothelkarzinom der Harnblase als neue prognostische Tumormarker

  2006cites this paper
• Nachweis von disseminierten Tumorzellen anhand einer Genexpression von CK-20 und MUC7 im Knochenmark bei Patienten mit lokal fortgeschrittenem Urothelkarzinom der Harnblase als neue prognostische Tumormarker

  2006cites this paper
• Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health.

  2005cites this paper
• The management of lymph node metastasis from bladder cancer.

  2005cites this paper
• Uroplakin II as a promising marker for molecular diagnosis of nodal metastases from bladder cancer: comparison with cytokeratin 20.

  2005cites this paper
• Molekulare Prognosemarker des Harnblasenkarzinoms

  2005cites this paper
• Detection and isolation of circulating tumor cells in urologic cancers: a review.

  2004cites this paper
• Detection of circulating MUC7‐positive cells by reverse transcription–polymerase chain reaction in bladder cancer patients

  2004cites this paper
• DIAGNOSTIKA RECIDIVUJÍCÍHO NÁDORU MOČOVÉHO MĚCHÝŘE POMOCÍ STANOVENÍ HLADIN CYTOKERATINU 8 A 18 V MOČI

  2003influential citation
• Mucin 7 and cytokeratin 20 as new diagnostic urinary markers for bladder tumor.

  2003cites this paper
• Detection and clinical relevance of tumor cells in blood and bone marrow of patients with colorectal cancer.

  2003cites this paper
• Diagnosis of recurrent bladder cancer: use of identification of cytokeratine 8 and 18 in urine sample

  2003cites this paper
• [Molecular markers of infiltrating cancer of the bladder].

  2002cites this paper
• The implication of the expression of three cytokines in carcinoma of bladder

  2002cites this paper
• DNA alterations in body fluids as molecular tumor markers for urological malignancies.

  2002cites this paper
• Effect of Blood Sample Handling and Reverse Transcriptase–Polymerase Chain Reaction Assay Sensitivity on Detection of CK20 Expression in Healthy Donor Blood

  2002influential citation
• Marqueurs moléculaires du cancer infiltrant de la vessie

  2002cites this paper